Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This study aims to quantify and follow the cumulative incidence of SARS-CoV-2 infection in the French population using serological tests and to assess the determinants of infection from Constances, E3N-E4N, ELFE-Epipage 2 and NutriNet-Santé cohorts.
Description: Simple and corrected estimate of the number of seropositive individuals/number of individuals at risk in different strata, based on weighting and calibration and taking into account the random cohort effect.
Measure: Cumulative incidence of SARS-Cov2 infection in the general population. Time: 8 monthsDescription: Decay kinetics estimated by mixed effect model with repeated data per subject
Measure: Maintenance over time of the acquisition of anti-SARS-Cov2 antibodies Time: 8 monthsDescription: Rate of use of care (medical care, hospitalization, center 15) linked to the occurrence of symptoms suggestive of a SARS-Cov2 infection, and share attributable to the infection during a time frame of 8 months
Measure: Rate of use of care (medical care, hospitalization, center 15) linked to the occurrence of symptoms suggestive of a SARS-Cov2 infection, and share attributable to the infection Time: 8 monthsDescription: Proportion of infections without reported or pauci-symptomatic symptoms and their epidemiological and social déterminants during a time frame of 8 months.
Measure: Proportion of infections without reported or pauci-symptomatic symptoms and their epidemiological and social determinants Time: 8 monthsDescription: Proportion of tests proposed, accepted, performed, based on social and demographic characteristics during a time frame of 8 months.
Measure: Proportion of tests proposed, accepted, performed, based on social and demographic characteristics Time: 8 monthsDescription: Proportion and intensity of use of barrier measures (hydroalcoholic gel, mask, social distancing, description of outings / reasons, duration, frequency) and association with the level of seroprevalence during a time frame of 8 months
Measure: Proportion and intensity of use of barrier measures (hydroalcoholic gel, mask, social distancing, description of outings / reasons, duration, frequency) and association with the level of seroprevalence Time: 8 monthsDescription: Strengths of associations between socio-behavioral factors and level of seroprevalence during a time frame of 8 months
Measure: Strengths of associations between socio-behavioral factors and level of seroprevalence Time: 8 months